Relapsing intracranial germ cell tumours warrant retreatment.

Date publication

juillet 2020

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32711377

Résumé

The optimal therapeutic strategy for relapsing intracranial germ cell tumours (IGCTs) has not been clearly established.

Mots clés

Germinoma, High-dose chemotherapy, Non-germinoma germ cell tumours, Outcome, Radiotherapy, Relapse

Référence

Eur. J. Cancer. 2020 Jul 22;136:186-194